TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01521143

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The study was terminated due to company restructuring and changes in drug development priorities.”

The sponsor’s own words in the registry.

Life of this trial

201220132014201520162017Started2012-01Registered2012-01-17Stopped2015-03Results posted2016-12-14

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Prima BioMed Ltd
Sponsor type
Industry
Conditions
Epithelial Ovarian Cancer
Interventions
Cvac; Placebo
Participants
91
Sites
8
Countries
Australia, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.